Bias in Spontaneous Reporting of Adverse Drug Reactions in Japan

• Shinichi Matsuda ,

  * E-mail: matsudasni@chugai-pharm.co.jp

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Kotonari Aoki,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Takuya Kawamata,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Tetsuji Kimotsuki,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Takumi Kobayashi,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Hiroshi Kuriki,

  Affiliation Clinical Development Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Terumi Nakayama,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Seigo Okugawa,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Yoshihiko Sugimura,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Minami Tomita,

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯
• Yoichiro Takahashi

  Affiliation Drug Safety Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan

  ⨯